PDF下载 ( 2153 KB)
多学科联合诊疗原发性肝脏神经内分泌瘤1例报告
DOI: 10.3969/j.issn.1001-5256.2023.06.024
伦理学声明：本例报告已获得患者知情同意。
利益冲突声明：本文不存在任何利益冲突。
作者贡献声明：赵凯越负责资料分析，撰写论文，修改论文；严哲负责收集资料、患者随访；黄缘负责拟定写作思路，指导撰写文章及审阅。
Multidisciplinary diagnosis and treatment of primary hepatic neuroendocrine tumor
-
-
Key words:
- Liver Diseases /
- Neuroendocrine Tumors /
- Therapeutics
-
图 1 肝胆胰脾超声检查
注：第二肝门处可见一低回声肿物，大小约8.7 cm×5.6 cm，边界清，累及右肝前叶及左肝内叶，周围为肝静脉、门静脉右支及下腔静脉。
Figure 1. Ultrasound examination of liver, bile, pancreas and spleen
图 2 全腹增强CT
注：a，肝脏S4/8/1扫及巨大混杂密度强化灶，动脉期明显强化，肝左及中静脉受累，肝总管、右侧肝内胆管轻度扩张，病灶最大截面61 mm×102 mm，病灶边缘见囊性水样密度灶，与主体肿块分界不清；b，肿物呈“快进快出”强化方式；c，肿物呈“快进快出”强化方式。
Figure 2. Whole abdomen enhanced CT
-
[1] WU WM, CHEN J, BAI CM, et al. The Chinese guidelines for the diagnosis and treatment of pancreatic neuroendocrine neoplasms (2020)[J]. Med J Peking Union Med Coll Hosp, 2021, 12(4): 460-480. DOI: 10.12290/xhyxzz.2021-0481.吴文铭, 陈洁, 白春梅, 等. 中国胰腺神经内分泌肿瘤诊疗指南(2020)[J]. 协和医学杂志, 2021, 12(4): 460-480. DOI: 10.12290/xhyxzz.2021-0481. [2] SONG JE, KIM BS, LEE CH. Primary hepatic neuroendocrine tumor: A case report and literature review[J]. World J Clin Cases, 2016, 4(8): 243-247. DOI: 10.12998/wjcc.v4.i8.243. [3] MENG XF, PAN YW, WANG ZB, et al. Primary hepatic neuroendocrine tumor case with a preoperative course of 26 years: A case report and literature review[J]. World J Gastroenterol, 2018, 24(24): 2640-2646. DOI: 10.3748/wjg.v24.i24.2640. [4] EDMONDSON HA. Tumors of the liver and intrahepatic bile ducts[M]. Washington: Armed Fores Institute of Pathology, 1958: 105-109. [5] BASUROY R, BOUVIER C, RAMAGE JK, et al. Delays and routes to diagnosis of neuroendocrine tumours[J]. BMC Cancer, 2018, 18(1): 1122. DOI: 10.1186/s12885-018-5057-3. [6] IWAO M, NAKAMUTA M, ENJOJI M, et al. Primary hepatic carcinoid tumor: case report and review of 53 cases[J]. Med Sci Monit, 2001, 7(4): 746-750. [7] LV Y, HUANG C, XU H, et al. Clinicopathological characteristics of the primary and metastatic hepatic neuroendocrine tumors and the relevant prognosis-related factors: A retrospective study of 81 cases in a single Chinese center[J]. J Cancer, 2018, 9(3): 479-487. DOI: 10.7150/jca.22157. [8] ZHENG QF, HE ZJ, NONG B. Advance in diagnosis of primary hepatic neuroendocrine neoplasms[J]. Chin J Gastroenterol, 2018, 23(8): 506-508. DOI: 10.3969/j.issn.1008-7125.2018.08.013.郑琴芳, 何志钧, 农兵. 原发性肝脏神经内分泌肿瘤诊断的研究进展[J]. 胃肠病学, 2018, 23(8): 506-508. DOI: 10.3969/j.issn.1008-7125.2018.08.013. [9] Chinese Society of Clinical Oncology Guidelines Working Committee. The Chinese Society of Clinical Oncology (CSCO): Clinical Guildlines for the Diagnosis and Treatment of Neuroendocrine Neoplasms, 2021[M]. Beijing: People's Medical Publishing House, 2021: 51.中国临床肿瘤学会指南工作委员会. CSCO神经内分泌肿瘤诊疗指南2021[M]. 北京: 人民卫生出版社, 2021: 51. [10] SONG S, KOH Y. Primary hepatic neuroendocrine tumor arising at a young age: Rare case report and literature review[J]. Korean J Gastroenterol, 2022, 79(1): 35-40. DOI: 10.4166/kjg.2021.139. [11] ZHAO S, CHENG C, ZUO CJ. The clinical value of combined 68Ga-SSA/18F-FDG PET/CT imaging in neuroendocrine neoplasms[J]. Chin J Nucl Med Mol Imaging, 2020, 40(1): 47-51. DOI: 10.3760/cma.j.issn.2095-2848.2020.01.012.赵帅, 程超, 左长京. 68Ga-SSA/18F-FDG PET/CT联合显像在神经内分泌肿瘤诊治中的应用价值[J]. 中华核医学与分子影像杂志, 2020, 40(1): 47-51. DOI: 10.3760/cma.j.issn.2095-2848.2020.01.012. [12] KNOX CD, ANDERSON CD, LAMPS LW, et al. Long-term survival after resection for primary hepatic carcinoid tumor[J]. Ann Surg Oncol, 2003, 10(10): 1171-1175. DOI: 10.1245/aso.2003.04.533. -
下载:
本文二维码
图(3)
计量
- 文章访问数: 338
- HTML全文浏览量: 55
- PDF下载量: 35
- 被引次数: 0
